Precision Neuroscience
company
About
Precision Neuroscience is a neural platform that engages in brain-computer interface technology.
- New York,New York,United States
- 11 - 50
- https://precisionneuro.io
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $34.30M
- Industries
- Medical,Medical Device,Neuroscience,Product Research
- Founded date
- May 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Precision Neuroscience Corporation
Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.The company was founded in 2021 and is based in New York.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$46.30M
Precision Neuroscience has raised a total of
$46.30M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | Series Unknown | $34.30M | — | — | — | Detail |
| May 25, 2021 | Series A | $12M | 2 |
B Capital Group
Steadview Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Precision Neuroscience is funded by 2 investors.
B Capital Group
and Steadview Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
B Capital Group
|
Yes | Series A |
|
Steadview Capital
|
Yes | Series A |
Employee Profiles
Number of Employee Profiles
4
Precision Neuroscience has 4 current employee profiles, including
Executive Demetrios Papageorgiou
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
